Skip to content

Development and Efficacy of Smartphone-Based Psychotherapy for Post-Mastectomy Pain Syndrome: A Multicenter, Sham-Controlled, Double-Blind, Randomized Parallel-Group Trial Using a Decentralized Clinical Trial Platform

Development and Efficacy of Smartphone-Based Psychotherapy for Post-Mastectomy Pain Syndrome: A Multicenter, Sham-Controlled, Double-Blind, Randomized Parallel-Group Trial Using a Decentralized Clinical Trial Platform - Development and Efficacy of Smartphone-Based Psychotherapy for Post-Mastectomy Pain Syndrome: A Multicenter, Sham-Controlled, Double-Blind, Randomized Parallel-Group Trial Using a Decentralized Clinical Trial Platform

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000059180
Enrollment
40
Registered
2025-09-24
Start date
2025-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Mastectomy Pain Syndrome

Interventions

smartphone-based psychotherapy + usual care sham app group + usual care

Sponsors

Nagoya City University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Diagnosed with breast cancer 2. More than one year post-breast cancer surgery with no recurrence 3. Aged 18 years or older at the time of obtaining consent 4. Persistent pain after breast cancer surgery(pain in the surgical site, underarm, or the arm on the operated side) present even one year after surgery, or pain in areas related to reconstructive surgery(such as the reconstructed site, back, or abdomen where surgery was performed for reconstruction) present one year after reconstruction, causing interference with daily life. The average pain intensity and interference with general activity in daily life, as measured by the Brief Pain Inventory(BPI) question 9-A, are 4 points or higher 5. Patients able to install and use the smartphone app on their own on an Android or iOS mobile device(OS version: iOS 15.0 or higher, Android 6.0 or higher) and use it throughout the study period

Exclusion criteria

Exclusion criteria: 1. Patients who are unable to read or write Japanese 2. Patients with pain believed to be caused by factors other than cancer surgery and who are receiving treatment for such pain 3. Patients with pain outside of the surgical site (wound), axilla, or arm, who are receiving treatment for such pain 4. Patients with psychiatric symptoms judged by the principal investigator or sub-investigators to be inappropriate for participation, such as dementia or cognitive impairment, severe depression with suicidal ideation, uncontrolled schizophrenia, or schizoaffective disorder 5. Patients with severe physical illnesses (e.g., severe respiratory diseases, cardiovascular diseases, central or peripheral nervous system disorders, musculoskeletal disorders) for whom psychotherapy is difficult 6. Patients who have previously received the same psychotherapy provided by this app 7. Other patients judged inappropriate for participation by the principal investigator or sub-investigators

Design outcomes

Primary

MeasureTime frame
Pain Interference: Brief Pain Inventory(BPI)

Secondary

MeasureTime frame
Pain intensity: Brief Pain Inventory(BPI) Fatigue and numbness: M.D.Anderson Symptom Inventory(MDASI) Pain acceptance: Chronic Pain Acceptance Questionnaire(CPAQ) Fear of recurrence: Fear of Cancer Recurrence Inventory-short form(FCRI-SF) Work productivity: Work Productivity and Activity Impairment Questionnaire(WPAI) Anxiety and depression: Hospital Anxiety and Depression Scale(HADS) Psychological flexibility: Acceptance and Action Questionnaire 2(AAQ-2) Values-based action: Valuing Questionnaire(VQ) Quality of life: EuroQol-5-deimensions(EQ5D)

Countries

Japan

Contacts

Public ContactMie Sakai

Nagoya City University Graduate School of Medical Sciences Department of Psychiatry and Cognitive Behavioral Medicine

info@sakura-pj.org090-7042-9321

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026